Latest Interviews
Showing 1–2 of 2 transcripts.
Clear all filters- Goldman Sachs19 min
Regeneron CEO Dr. Leonard Schleifer on Science-Driven Success
Dr. Leonard Schleifer, John Waldron
Founded in 1988 by MD-PhDs Leonard Schleifer and George Yancopoulos, Regeneron rejects top-down target selection to pursue science-driven therapeutics, enduring two decades of losses before achieving profitability in 2011. The company currently employs 15,000 people and markets Dupixent as its flagship treatment for diverse allergic conditions while leveraging genomic data from 3 million individuals to advance research in areas like obesity and cancer. Under Schleifer's unique leadership style that eschews quarterly earnings guidance, Regeneron is expanding its genetic sequencing efforts to 50 million people and integrating AI to refine diagnostic precision without compromising its "do well by doing good" ethical mandate.
- Goldman Sachs15 min
Rami Rahim, CEO of Juniper Networks
Juniper Networks CEO Rami Rahim positions the company as a critical architect of global connectivity by pivoting toward software-defined "experience-first networking" and AI-driven analytics via its Marvis engine to predict network failures before they occur. This strategic evolution addresses the surging demands of 5G infrastructure, cloud computing, and massive data generation while aiming to simplify enterprise operations and reduce legacy maintenance costs. Rahim further advocates for government-backed broadband investment and gradual hybrid work models to modernize office environments, viewing these macro shifts as significant growth opportunities for Juniper's next decade.